US 8,207,216 · Application 12/488,433 · Granted Jun 26, 2012
US 8,207,216
Benzofuran-3-yl(indol-3-yl) maleimides as potent gsk3 inhibitors
Estimated expiration
March 16, 2028
1y 133d remaining
Earliest effective filing
Dec 19, 2007
+ 20 years
Dec 19, 2027
PTA +88d
Mar 16, 2028
No TD
—
Final
Mar 16, 2028
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- June 19, 2009
- Earliest effective filing
- December 19, 2007
- Issue date
- June 26, 2012
- PTA
- +88 days
- Base expiry (before PTA)
- December 19, 2027
December 19, 2007 + 20 years = December 19, 2027 + 88 PTA days = March 16, 2028
- Continuation-in-part of application PCTUS2007088248, filed Dec 19, 2007
- PRO60/870,825 — Provisional — not used for base term
- PRO60/870,825 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 12/488,433 · US 8,207,216
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 8,207,216: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US8207216Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.